The International Probiotics Association (IPA) has announced an expansion of its scope to include prebiotics, postbiotics, and synbiotics within the human, infant, and companion animal segments of food and dietary supplements.
Photo © AdobeStock.com/picture-waterfall
The International Probiotics Association (IPA) has announced an expansion of its scope to include prebiotics, postbiotics, and synbiotics within the human, infant, and companion animal segments of food and dietary supplements. The expansion was voted on by IPA’s Board of Directors as part of the association’s strategy to “help the ‘biotics’ industry grow in response to market demands and strengthen its ownership within the ‘biotics’ categories.”
“It is a natural progression for the evolution of IPA, and we are delighted to announce this expansion in strategic focus,” said George Paraskevakos, executive director, IPA, in a press release. “We will continue our solid path of driving and advancing the probiotic category as we replicate our past achievements in these additional ‘biotic’ categories.”
Amy Smith, the newly appointed president of IPA, emphasizes that the move will only strengthen the organization’s efforts, rather than impede IPA’s focused efforts on the probiotic category. “We are better together,” she states.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.